Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Bartakke S, Abla O, Weitzman S. Successful use of alemtuzumab in a child with refractory peripheral T-cell posttransplant lymphoproliferative disorder. J Pediatr Hematol Oncol 2008;30:787-8. [PMID: 19011483 DOI: 10.1097/MPH.0b013e318182e799] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]

For:	Bartakke S, Abla O, Weitzman S. Successful use of alemtuzumab in a child with refractory peripheral T-cell posttransplant lymphoproliferative disorder. J Pediatr Hematol Oncol 2008;30:787-8. [PMID: 19011483 DOI: 10.1097/MPH.0b013e318182e799] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]

Number	Cited by Other Article(s)
1	Risk Factors and Prognosis in T-Cell Posttransplantation Lymphoproliferative Diseases. Transplantation 2013;95:479-88. [DOI: 10.1097/tp.0b013e3182762e07] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse
2	Where there are no randomized, phase 3 trials: what is a doctor to do? J Pediatr Hematol Oncol 2008;30:719-20. [PMID: 19011465 DOI: 10.1097/mph.0b013e318182e774] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse